The cardiovascular safety profile of renzapride, a novel treatment for irritable bowel syndrome.
about
Systematic review: cardiovascular safety profile of 5-HT(4) agonists developed for gastrointestinal disordersSerotonin pharmacology in the gastrointestinal tract: a review.A review of irritable bowel syndrome and an update on therapeutic approaches.Efficacy and tolerability of renzapride in irritable bowel syndrome: a meta-analysis of randomized, controlled clinical trials including 2528 patientsThe safety of novel drugs used to treat irritable bowel syndrome.New therapeutic perspectives in irritable bowel syndrome: Targeting low-grade inflammation, immuno-neuroendocrine axis, motility, secretion and beyond.[New drugs for the treatment of constipation].
P2860
Q34166903-052500BF-5238-4D21-84D9-6D232F66A46AQ37132811-A7B706B1-FDF4-41F6-9609-5A6771C111A3Q37142056-82EB6663-6DB1-45B3-9D9A-E97CBB35104BQ37636847-FCEC7C7A-6BC4-4605-949E-67A6803BE06CQ38199522-2DDC8F27-B6E3-4DC7-A566-CA818AE09A1CQ42695148-076B7C31-DB5A-4575-A241-0F5C49576327Q42949767-44ED6A3D-E553-4A3A-937C-EA7175F0EA00
P2860
The cardiovascular safety profile of renzapride, a novel treatment for irritable bowel syndrome.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
The cardiovascular safety prof ...... for irritable bowel syndrome.
@en
type
label
The cardiovascular safety prof ...... for irritable bowel syndrome.
@en
prefLabel
The cardiovascular safety prof ...... for irritable bowel syndrome.
@en
P2860
P1476
The cardiovascular safety prof ...... for irritable bowel syndrome.
@en
P2093
N L Meyers
R I Hickling
P2860
P304
P356
10.1177/147323000703500613
P577
2007-11-01T00:00:00Z